David Brosh

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

Donald S. Silverberg, Dov Wexler, Miriam Blum et al. · Journal of the American College of Cardiology · 2000 · 730 citations

Medicine, Cardiology, Pharmacotherapy +14

Main Risk Factors for Nephropathy in Type 2 Diabetes Mellitus Are Plasma Cholesterol Levels, Mean Blood Pressure, and Hyperglycemia

Mordchai Ravid, David Brosh, D Ravid-Safran et al. · Archives of Internal Medicine · 1998 · 453 citations · Full text

Medicine, Internal Medicine, Nephrology +14

Effect of No-Reflow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction on Six-Month Mortality

David Brosh, Abid Assali, Aviv Mager et al. · The American Journal of Cardiology · 2006 · 216 citations

Medicine, Cardiology, Internal Medicine +11

Comparison of the Predictive Value of Four Different Risk Scores for Outcomes of Patients With ST-Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Eli I. Lev, Ran Kornowski, Hana Vaknin‐Assa et al. · The American Journal of Cardiology · 2008 · 127 citations

Medicine, Cardiology, Internal Medicine +14

Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease

Alejandro Chade, David Brosh, Stuart T. Higano et al. · Kidney International · 2006 · 110 citations · Full text

Medicine, Cardiology, Internal Medicine +12